Early Decrease in Serum Amphiregulin or Vascular Endothelial Growth Factor Levels Predicts Sorafenib Efficacy in Hepatocellular Carcinoma
Oncology Reports - Greece
doi 10.3892/or.2018.6922
Full Text
Open PDFAbstract
Available in full text
Date
December 10, 2018
Authors
Publisher
Spandidos Publications